RPG Life Sciences Q1 FY27 results: Revenue up 15.8% YoY, PAT up 16.3%

Exceptional ItemRelated Party TransactionsResults View source PDF Explain this filing

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹2906.00

prior close

₹2950.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%-2.5% vs market

Pharmaceuticals peers, median of 160sector+0.8%-2.8% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 2.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.5

10m

-3.4

15m

-4.9

30m

-1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.0+0.5-2.5+0.8-2.8

Next day

-4.1-0.1-4.0+0.0-4.1

-4.7+1.0-5.7+0.1-4.8

-5.1+2.3-7.4+0.6-5.7

-6.0+2.8-8.7+1.0-7.0

-6.2+4.1-10.3+0.6-6.9

-8.8+4.5-13.3+1.6-10.4

15d

-8.8+4.8-13.6+0.5-9.3

-9.0+6.4-15.4+2.1-11.1

+6.8+5.5+1.3+3.3+3.5

+3.5-1.7+5.3-2.2+5.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

RPG Life Sciences reported Q1 FY27 standalone revenue of Rs 19,569 lakhs, up 15.8% YoY from Rs 16,892 lakhs. PAT rose 16.3% to Rs 3,057 lakhs versus Rs 2,629 lakhs. EPS at Rs 18.49 versus Rs 15.90. Total income stood at Rs 19,985 lakhs. Exceptional item of Rs 110 lakhs came from fire incident insurance claim settlement. The Board approved transferring the API division to wholly owned subsidiary RPG Active Pharma Limited.

Likely market impact

Steady revenue and profit growth YoY with stable margins. Insurance settlement adds a one-time boost. API division restructuring to WOS is pending approvals.